Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 106, doi. 10.1177/1758834016676703
- By:
- Publication type:
- Article
Works matching IS 17588340 AND DT 2017 AND VI 9 AND IP 2
Results: 6
1
2
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 75, doi. 10.1177/1758834016676011
- By:
- Publication type:
- Article
3
Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 68, doi. 10.1177/1758834016675099
- By:
- Publication type:
- Article
4
Refractory carcinoid syndrome: a review of treatment options.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 127, doi. 10.1177/1758834016675803
- By:
- Publication type:
- Article
5
Progress with palbociclib in breast cancer: latest evidence and clinical considerations.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 83, doi. 10.1177/1758834016677961
- By:
- Publication type:
- Article
6
Muscle spasms: an unexpected adverse drug reaction of pemetrexed?
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 2, p. 138, doi. 10.1177/1758834016677941
- By:
- Publication type:
- Article